Remdesivir

Remdesivir, sold under the brand name Veklury, is a broad-spectrum antiviral medication developed by the biopharmaceutical company Gilead Sciences. It is administered via injection into a vein. Remdesivir is approved or authorized for emergency use to treat COVID‑19 in around 50 countries. Remdesivir has been authorized for emergency use in India, Singapore, and approved for use in Japan, the European Union, the United States, and Australia for people with severe symptoms. It also received approval in the United Kingdom in May 2020; however, it was going to be rationed due to limited supply. It may shorten the time it takes to recover from the infection.